Dr David Millrine
Research Associate
- millrined@cardiff.ac.uk
- Adeilad Tenovus, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4XN
Cyhoeddiadau
2023
- Millrine, D., Rice, C. M., Fernandez, J. U. and Jones, S. A. 2023. Tracking the host response to infection in peritoneal models of acute resolving inflammation. In: Jenkins, B. ed. Inflammation and Cancer., Vol. 2691. Methods in Molecular Biology New York: Springer, pp. 81-95., (10.1007/978-1-0716-3331-1_7)
2022
- Millrine, D., Jenkins, R. H., Hughes, S. T. O. and Jones, S. A. 2022. Making sense of IL-6 signalling cues in pathophysiology. FEBS Letters 596(5), pp. 567-588. (10.1002/1873-3468.14201)
2019
- Twohig, J. P. et al. 2019. Activation of naïve CD4+ T cells re-tunes STAT1 signaling to deliver unique cytokine responses in memory CD4+ T cells. Nature Immunology 20, pp. 458-470. (10.1038/s41590-019-0350-0)
2018
- Gemechu, Y. et al. 2018. Humanized cereblon mice reveal two distinct pathways of immunomodulatory drugs. Proceedings of the National Academy of Sciences 115(46), pp. 11802-11807. (10.1073/pnas.1814446115)
- Fernandez, J. U., Millrine, D. and Jones, S. 2018. Tracking competent host defence to chronic inflammation: An In Vivo model of peritonitis. In: Jenkins, B. J. ed. Inflammation and Cancer., Vol. 1725. Methods in Molecular Biology New York, NY: Springer, pp. 65-75., (10.1007/978-1-4939-7568-6_6)
2017
- Millrine, D. and Kishimoto, T. 2017. A brighter side to thalidomide: its potential use in immunological disorders. Trends in Molecular Medicine 23(4), pp. 348-361. (10.1016/j.molmed.2017.02.006)